2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance
Authors:
Tomáš Freiberger
Published in:
AtheroRev 2023; 8(3): 135-144
Category:
Guidelines
Sources
Číselná označení citované literatury odkazují na citace v originální verzi aktualizace konsenzu:
Cuchel M, Raal FJ, Hegele RA et al. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance. Eur Heart J 2023; 44(25): 2277–2291. Dostupné z DOI: <https://doi: 10.1093/eurheartj/ehad197>.
Labels
Angiology Diabetology Internal medicine Cardiology General practitioner for adultsArticle was published in
Athero Review
2023 Issue 3
Most read in this issue
- Measuring lipoprotein(a) concentrations: what and how do we measure and where do we go from here?
- 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance
- Anti-obesity drug with exceptional benefit for preventive cardiology: current results of the SELECT trial
- New treatment possibilities of homozygous familial hypercholesterolemia